Medigene AG (MDGEF)
OTCMKTS · Delayed Price · Currency is USD
2.590
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Medigene AG Revenue
Medigene AG had revenue of 1.46M EUR in the quarter ending June 30, 2024, a decrease of -6.00%. This brings the company's revenue in the last twelve months to 7.45M, down -17.51% year-over-year. In the year 2023, Medigene AG had annual revenue of 6.03M, down -80.69%.
Revenue (ttm)
7.45M EUR
Revenue Growth
-17.51%
P/S Ratio
0.09
Revenue / Employee
85.59K EUR
Employees
87
Market Cap
699.60K USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.03M | -25.21M | -80.69% |
| Dec 31, 2022 | 31.25M | 20.78M | 198.64% |
| Dec 31, 2021 | 10.46M | 2.46M | 30.75% |
| Dec 31, 2020 | 8.00M | -2.51M | -23.87% |
| Dec 31, 2019 | 10.51M | 2.94M | 38.74% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sorrento Therapeutics | 64.27M |
| SQZ Biotechnologies Company | 12.12M |
| EV Biologics | 9.47M |
| Helix BioMedix | 2.07M |
| Lipella Pharmaceuticals | 389.78K |
Medigene AG News
- 1 year ago - Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S. - GlobeNewsWire
- 1 year ago - Medigene AG announces closing of its first SEPA tranche - GlobeNewsWire
- 1 year ago - IRW-News: Medigene AG: Medigene AG übt erste Tranche des Standby Equity Purchase Agreements aus - Onvista
- 1 year ago - Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers - GlobeNewsWire
- 1 year ago - KPMG: 94% of Life Sciences CEOs to Expand Workforce Over the Next 3 Years - CEOWORLD magazine
- 1 year ago - Medigene AG reports Q3 results - Seeking Alpha
- 1 year ago - Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021 - GlobeNewsWire
- 1 year ago - Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform - GlobeNewsWire